These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 29770170)
1. Targeted therapy or immunotherapy? Optimal treatment in hepatocellular carcinoma. Contratto M; Wu J World J Gastrointest Oncol; 2018 May; 10(5):108-114. PubMed ID: 29770170 [TBL] [Abstract][Full Text] [Related]
2. Systemic targeted and immunotherapy for advanced hepatocellular carcinoma. Cersosimo RJ Am J Health Syst Pharm; 2021 Jan; 78(3):187-202. PubMed ID: 33211092 [TBL] [Abstract][Full Text] [Related]
3. Role of immunotherapy in the management of hepatocellular carcinoma: current standards and future directions. Weinmann A; Galle PR Curr Oncol; 2020 Nov; 27(Suppl 3):S152-S164. PubMed ID: 33343209 [TBL] [Abstract][Full Text] [Related]
4. First-Line Targeted Therapy for Hepatocellular Carcinoma: Role of Atezolizumab/Bevacizumab Combination. Tella SH; Kommalapati A; Mahipal A; Jin Z Biomedicines; 2022 Jun; 10(6):. PubMed ID: 35740326 [TBL] [Abstract][Full Text] [Related]
5. Drug Treatment for Advanced Hepatocellular Carcinoma: First-Line and Beyond. Feng MY; Chan LL; Chan SL Curr Oncol; 2022 Aug; 29(8):5489-5507. PubMed ID: 36005172 [TBL] [Abstract][Full Text] [Related]
7. Immunotherapy in Hepatocellular Carcinoma: Is There a Light at the End of the Tunnel? Mahipal A; Tella SH; Kommalapati A; Lim A; Kim R Cancers (Basel); 2019 Jul; 11(8):. PubMed ID: 31366113 [TBL] [Abstract][Full Text] [Related]
8. Evaluating the Safety and Efficacy of Nivolumab in Patients with Advanced Hepatocellular Carcinoma: Evidence to Date. Tella SH; Mahipal A; Kommalapati A; Jin Z Onco Targets Ther; 2019; 12():10335-10342. PubMed ID: 31819517 [TBL] [Abstract][Full Text] [Related]
9. Molecular targeted and immune checkpoint therapy for advanced hepatocellular carcinoma. Liu Z; Lin Y; Zhang J; Zhang Y; Li Y; Liu Z; Li Q; Luo M; Liang R; Ye J J Exp Clin Cancer Res; 2019 Nov; 38(1):447. PubMed ID: 31684985 [TBL] [Abstract][Full Text] [Related]
10. Recent Advances in Systemic Therapy for Hepatocellular Carcinoma in an Aging Society: 2020 Update. Kudo M Liver Cancer; 2020 Dec; 9(6):640-662. PubMed ID: 33442538 [TBL] [Abstract][Full Text] [Related]
12. Navigating the new landscape of second-line treatment in advanced hepatocellular carcinoma. Rimassa L; Wörns MA Liver Int; 2020 Aug; 40(8):1800-1811. PubMed ID: 32432830 [TBL] [Abstract][Full Text] [Related]
13. Pharmacogenetics of the systemic treatment in advanced hepatocellular carcinoma. De Mattia E; Cecchin E; Guardascione M; Foltran L; Di Raimo T; Angelini F; D'Andrea M; Toffoli G World J Gastroenterol; 2019 Aug; 25(29):3870-3896. PubMed ID: 31413525 [TBL] [Abstract][Full Text] [Related]
14. Review article: systemic treatment of hepatocellular carcinoma. Pinter M; Peck-Radosavljevic M Aliment Pharmacol Ther; 2018 Sep; 48(6):598-609. PubMed ID: 30039640 [TBL] [Abstract][Full Text] [Related]